Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Sell
7,327
-7,380
-50% -$11.7M 0.05% 339
2026
Q1
$19.4M Buy
14,707
+5,124
+53% +$7.02M 0.07% 278
2025
Q4
$10.3M Buy
9,583
+345
+4% +$360K 0.04% 392
2025
Q3
$8.94M Sell
9,238
-3,213
-26% -$2.53M 0.03% 432
2025
Q2
$9.98M Sell
12,451
-15,332
-55% -$11M 0.04% 405
2025
Q1
$18.4M Buy
27,783
+15,382
+124% +$11.2M 0.08% 266
2024
Q4
$8.59M Sell
12,401
-30
-0.2% -$21.5K 0.04% 426
2024
Q3
$10.4M Buy
12,431
+394
+3% +$352K 0.04% 397
2024
Q2
$12.3M Sell
12,037
-4,694
-28% -$4.51M 0.05% 356
2024
Q1
$16.2M Sell
16,731
-1,501
-8% -$1.33M 0.08% 298
2023
Q4
$13.8M Buy
18,232
+13
+0.1% +$8.58K 0.07% 319
2023
Q3
$10.7M Buy
18,219
+723
+4% +$480K 0.06% 373
2023
Q2
$12.7M Sell
17,496
-22,336
-56% -$15.2M 0.06% 358
2023
Q1
$27.1M Sell
39,832
-4,123
-9% -$2.65M 0.13% 189
2022
Q4
$24M Buy
43,955
+565
+1% +$296K 0.11% 226
2022
Q3
$18M Buy
43,390
+25,882
+148% +$13M 0.08% 271
2022
Q2
$8.33M Sell
17,508
-12,065
-41% -$6.73M 0.04% 556
2022
Q1
$19.8M Sell
29,573
-6,824
-19% -$4.57M 0.07% 298
2021
Q4
$29M Sell
36,397
-2
-0% -$1.59K 0.11% 219
2021
Q3
$27.1M Sell
36,399
-3,403
-9% -$2.67M 0.12% 202
2021
Q2
$27.5M Buy
39,802
+12,802
+47% +$8.44M 0.13% 197
2021
Q1
$16.7M Sell
27,000
-73
-0.3% -$40.5K 0.09% 241
2020
Q4
$13.2M Sell
27,073
-874
-3% -$368K 0.08% 276
2020
Q3
$10.3M Buy
27,947
+3,922
+16% +$1.47M 0.07% 295
2020
Q2
$8.84M Sell
24,025
-3,902
-14% -$1.22M 0.06% 323
2020
Q1
$7.31M Buy
27,927
+2,054
+8% +$584K 0.06% 326
2019
Q4
$7.66M Buy
+25,873
New +$6.99M 0.04% 418
2018
Q1
Sell
-103,455
Closed -$18M 601
2017
Q4
$18M Buy
+103,455
New +$18.3M 0.09% 223

Other funds holding ASML

Calamos Advisors's ASML Position: Q2 2026 in Review

Calamos Advisors reduced its ASML (ASML) stake by 50% in Q2 2026, selling an estimated $11.7M and leaving 7,327 shares worth $14.6M. The position accounts for 0.05% of the portfolio, ranked #339.

Calamos Advisors first reported a position in ASML in Q4 2017 and has held it in 28 quarters since. The position peaked at $29M in Q4 2021. 1,552 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Calamos Advisors held 7,327 shares of ASML worth $14.6M as of Q2 2026.
  • Calamos Advisors sold 7,380 ASML shares in Q2 2026, an estimated $11.7M.
  • ASML made up 0.05% of Calamos Advisors's portfolio in Q2 2026, its #339 holding.
  • Calamos Advisors first reported a position in ASML in Q4 2017 and has held it in 28 quarters since.
  • Calamos Advisors's ASML position peaked at $29M in Q4 2021.
  • 1,552 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.